arrow
M

Marc Humbert

Assistance Publique Hôpitaux de Paris
H指数:177
被引数:15.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MicroRNA-224 orchestrates BMP and TGFβ signaling and is a therapeutic target in preclinical pulmonary arterial hypertension

MicroRNA-224调控BMP和TGFβ信号通路,是肺动脉高压前临床治疗的一个治疗靶点

2026-09-020
PRE
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension

sotatercept可降低肺动脉高压患者中的骨形态发生蛋白信号传导

2026-05-200
PRE
Long-term outcomes of Qing-Dai-induced pulmonary arterial hypertension

青黛诱导的肺动脉高压的长期结局

2025-12-150
PRE
Chronic thromboembolic pulmonary hypertension associated with venous thoracic outlet syndrome: a retrospective case series

慢性血栓栓塞性肺动脉高压与静脉胸廓出口综合征相关:一项回顾性病例系列研究

2025-12-010
PRE
Results of the MACiTEPH study of macitentan for the treatment of inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension

MACiTEPH研究的麦卡替尼治疗不可手术或持续/复发性慢性血栓栓塞性肺动脉高压的结果

2025-11-240
PRE
Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunction

Orai1抑制剂CM5480与特异性疗法的联合应用减轻了肺动脉高压及其心脏功能障碍

2025-11-101
PRE
The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomy

慢性血栓栓塞性肺动脉高压中的激活素途径: 动脉内膜切除术后残余肺动脉高压的潜在生物标志物

2025-11-030
PRE
Evolving paradigms in pulmonary hypertension: Highlights of the 6th French Pulmonary Hypertension Network Meeting

肺动脉高压的发展范式: 第六届法国肺动脉高压网络会议的亮点

2025-10-010
OAAI
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis

sotatercept 用于诊断后第一年的肺动脉高压

2025-09-012
PRE
Combined Multimodal Therapy in High-Risk Patients with Chronic Thromboembolic Pulmonary Hypertension and Both Distal and Proximal Lesions: A Prospective Observational Cohort Study

联合多模式疗法在伴有远端和近端病灶的高危慢性血栓栓塞性肺动脉高压患者中的应用:一项前瞻性观察性队列研究

2025-08-200
PRE